aap Implantate AG (ETR:AAQ1)
Germany · Delayed Price · Currency is EUR 1.990
0.00 (0.00%)
May 29, 2026, 5:35 PM CET
aap Implantate AG Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 12.8 | 12.29 | 11.67 | 11.66 | 12.3 |
| 12.8 | 12.29 | 11.67 | 11.66 | 12.3 | |
Revenue Growth (YoY) | 4.16% | 5.38% | 0.08% | -5.23% | 30.78% |
Cost of Revenue | 2.27 | 2.18 | 2.13 | 1.45 | 1.75 |
Gross Profit | 10.53 | 10.12 | 9.54 | 10.21 | 10.55 |
Selling, General & Admin | 6.42 | 6.3 | 6.97 | 6.88 | 6.72 |
Other Operating Expenses | 4.86 | 4.62 | 4.62 | 5.7 | 5.14 |
Operating Expenses | 13.25 | 12.9 | 15.57 | 14.25 | 13.7 |
Operating Income | -2.71 | -2.78 | -6.03 | -4.04 | -3.15 |
Interest Expense | -0.07 | -0.17 | -0.17 | -0.37 | -0.5 |
Interest & Investment Income | 0.01 | 0.01 | 0.01 | 0.02 | 0.03 |
Currency Exchange Gain (Loss) | 0.32 | -0.35 | 0.03 | 0.13 | 0.22 |
Other Non Operating Income (Expenses) | -0.11 | 0.06 | 0.14 | 0.06 | 0.07 |
EBT Excluding Unusual Items | -2.56 | -3.23 | -6.02 | -4.21 | -3.34 |
Merger & Restructuring Charges | - | - | -0.5 | - | -0.1 |
Gain (Loss) on Sale of Assets | - | - | - | - | 0.07 |
Legal Settlements | - | - | - | - | -0.2 |
Other Unusual Items | -0.04 | - | -1 | 0.6 | 0.7 |
Pretax Income | -2.6 | -3.23 | -7.52 | -3.61 | -2.86 |
Income Tax Expense | -0.01 | 0.41 | 0.45 | -1.05 | -0.34 |
Earnings From Continuing Operations | -2.59 | -3.63 | -7.96 | -2.56 | -2.52 |
Net Income | -2.59 | -3.63 | -7.96 | -2.56 | -2.52 |
Net Income to Common | -2.59 | -3.63 | -7.96 | -2.56 | -2.52 |
Shares Outstanding (Basic) | 14 | 10 | 8 | 6 | 5 |
Shares Outstanding (Diluted) | 14 | 10 | 8 | 6 | 5 |
Shares Change (YoY) | 34.34% | 23.90% | 39.27% | 21.18% | 53.27% |
EPS (Basic) | -0.19 | -0.35 | -0.96 | -0.43 | -0.51 |
EPS (Diluted) | -0.19 | -0.35 | -0.96 | -0.43 | -0.51 |
Free Cash Flow | -1.84 | -1.36 | -3.13 | -2.24 | -2.8 |
Free Cash Flow Per Share | -0.13 | -0.13 | -0.38 | -0.38 | -0.57 |
Gross Margin | 82.25% | 82.31% | 81.76% | 87.60% | 85.76% |
Operating Margin | -21.20% | -22.59% | -51.69% | -34.67% | -25.63% |
Profit Margin | -20.19% | -29.53% | -68.26% | -22.00% | -20.50% |
Free Cash Flow Margin | -14.37% | -11.10% | -26.86% | -19.19% | -22.76% |
EBITDA | -1.78 | -1.83 | -2.74 | -3.2 | -2.25 |
EBITDA Margin | -13.89% | -14.89% | -23.48% | -27.46% | -18.32% |
D&A For EBITDA | 0.94 | 0.95 | 3.29 | 0.84 | 0.9 |
EBIT | -2.71 | -2.78 | -6.03 | -4.04 | -3.15 |
EBIT Margin | -21.20% | -22.59% | -51.69% | -34.67% | -25.63% |